SCHEMBL21844944

SCHEMBL21844944

O=C(Nc1cccc(F)c1)c1cccc(CCN2CCC(O)CC2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 3/20 0.54
▸ HTR1D P28221 3/20 0.54
▸ HTR1B P28222 3/20 0.54
▸ ACKR3 P25106 2/20 0.53
▸ NPC1 O15118 3/20 0.50
▸ RAB9A P51151 3/20 0.50
▸ HPGD P15428 1/20 0.50
▸ ALDH1A1 P00352 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ OPRM1 P35372 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ KCNK3 O14649 1/20 0.48
▸ TP53 P04637 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ UBE2M P61081 1/20 0.47
▸ DCUN1D1 Q96GG9 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ HRH3 Q9Y5N1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21844837 0.93 HTR2A (0.47) HTR1AHTR1DHTR1BACKR3NPC1
SCHEMBL19156951 0.89 NPC1 (0.52) HTR1AHTR1DHTR1BACKR3NPC1
SCHEMBL21844832 0.88 ACKR3 (0.50) HTR1AHTR1DHTR1BACKR3NPC1
SCHEMBL21844945 0.87 ACKR3 (0.53) ACKR3NPC1RAB9AALDH1A1KMT2A
SCHEMBL21844943 0.87 ALDH1A1 (0.54) HTR1AHTR1DHTR1BACKR3RAB9A
SCHEMBL19157407 0.86 HTR1A (0.56) HTR1AHTR1DHTR1BACKR3NPC1
SCHEMBL21844836 0.86 ACKR3 (0.51) HTR1AHTR1DHTR1BACKR3KMT2A
SCHEMBL20083898 0.85 KDR (0.44) HTR1AHTR1DHTR1BACKR3KMT2A
SCHEMBL21844835 0.83 ROCK2 (0.54) HTR1AHTR1DHTR1BACKR3HTR2A
SCHEMBL20083978 0.81 ACKR3 (0.43) HTR1AHTR1DHTR1BACKR3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
Send feedback